Medmain, a Japanese pathology AI startup, has raised 3.3M USD (total 18M USD), with investments from One Capital, Niremia Collective, and Plug and Play

Medmain Inc., a Japanese medtech startup offering the AI-powered digital pathology platform PidPort, has raised $3.3 million in a funding round led by One Capital, with participation from Niremia Collective and Plug and Play, bringing its total equity funding to $18 million. The funds will be used to enhance product development, invest in digitalization infrastructure, strengthen sales, pursue regulatory approvals, and support international expansion.